These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35925473)

  • 1. Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea.
    Yang R; Liu C; Liu W; Luo J; Cheng S; Mu X
    Dermatol Ther (Heidelb); 2022 Oct; 12(10):2285-2294. PubMed ID: 35925473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The toxic edge-A novel treatment for refractory erythema and flushing of rosacea.
    Friedman O; Koren A; Niv R; Mehrabi JN; Artzi O
    Lasers Surg Med; 2019 Apr; 51(4):325-331. PubMed ID: 30311683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled, split-face study of botulinum toxin and broadband light for the treatment of erythematotelangiectatic rosacea.
    Tong Y; Luo W; Gao Y; Liu L; Tang Q; Wa Q
    Dermatol Ther; 2022 May; 35(5):e15395. PubMed ID: 35187781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsed dye laser followed by intradermal botulinum toxin type-A in the treatment of rosacea-associated erythema and flushing.
    Al-Niaimi F; Glagoleva E; Araviiskaia E
    Dermatol Ther; 2020 Nov; 33(6):e13976. PubMed ID: 32633449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea.
    Park KY; Kwon HJ; Kim JM; Jeong GJ; Kim BJ; Seo SJ; Kim MN
    Ann Dermatol; 2018 Dec; 30(6):688-693. PubMed ID: 33911508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for the treatment of refractory erythema and flushing of rosacea.
    Park KY; Hyun MY; Jeong SY; Kim BJ; Kim MN; Hong CK
    Dermatology; 2015; 230(4):299-301. PubMed ID: 25765295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.
    Luque A; Rojas AP; Ortiz-Florez A; Perez-Bernal J
    J Clin Aesthet Dermatol; 2021 Mar; 14(3):42-45. PubMed ID: 33841616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating rosacea with botulism toxin: Protocol for a systematic review and meta-analysis.
    He G; Yang Q; Wu J; Huang Y; Zheng H; Cheng H
    J Cosmet Dermatol; 2024 Jan; 23(1):44-61. PubMed ID: 37605478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema.
    Kim MJ; Kim JH; Cheon HI; Hur MS; Han SH; Lee YW; Choe YB; Ahn KJ
    Dermatol Surg; 2019 Sep; 45(9):1155-1162. PubMed ID: 30730346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial flushing and erythema of rosacea improved by carvedilol.
    Seo BH; Kim DH; Suh HS; Choi YS
    Dermatol Ther; 2020 Nov; 33(6):e14520. PubMed ID: 33174351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness-to-Pay and Benefit-Cost Analysis of Botulinum Toxin for the Treatment of Rosacea in China: Findings from a Web-Based Survey.
    Yang X; Ouyang Y; Deng Y; Xiao Y; Tang Y; Jian D; Li J; Xie H; Huang Y
    Patient Prefer Adherence; 2021; 15():1197-1205. PubMed ID: 34113082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A split-face study using botulinum toxin type B to decrease facial erythema index.
    Oh YJ; Lee NY; Suh DH; Koh JS; Lee SJ; Shin MK
    J Cosmet Laser Ther; 2011 Oct; 13(5):243-8. PubMed ID: 21848448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea.
    Bloom BS; Payongayong L; Mourin A; Goldberg DJ
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S9-16. PubMed ID: 25548852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol.
    Pietschke K; Schaller M
    J Dermatolog Treat; 2018 May; 29(3):310-313. PubMed ID: 28748731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol ameliorates persistent erythema of erythematotelangiectatic rosacea by regulating the status of anxiety/depression.
    Li J; Tang JY; Fu J; Zhang MW; Wan M; Chen DW; Chen QQ; Li X; Song GJ; Ni RR; Song ZQ
    J Dermatol; 2022 Nov; 49(11):1139-1147. PubMed ID: 35904063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy and Safety of Botulinum Toxin A for the Treatment of Rosacea: A Systematic Review.
    Alsaati AA; Alsaadoun D; Kinkar LI; Alkhamis RS; Ahmed WA; Almathami AH
    Cureus; 2023 Dec; 15(12):e51304. PubMed ID: 38288198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life.
    Tan SR; Tope WD
    J Am Acad Dermatol; 2004 Oct; 51(4):592-9. PubMed ID: 15389196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction to: Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea.
    Yang R; Liu C; Liu W; Luo J; Cheng S; Mu X
    Dermatol Ther (Heidelb); 2022 Oct; 12(10):2295. PubMed ID: 36098878
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
    Logger JGM; Olydam JI; Driessen RJB
    J Am Acad Dermatol; 2020 Oct; 83(4):1088-1097. PubMed ID: 32360760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of mesoderm introduction of compound glycyrrhizin injection on the treatment of rosacea.
    Li S; Zhao X; Chen Y; Liu J
    Skin Res Technol; 2023 May; 29(5):e13328. PubMed ID: 37231926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.